Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 12,186 | 7,040 | 1,844 | 2,664 | 364 |
| Operating Income | -12,186 | -7,040 | -1,844 | -2,664 | -364 |
| Interest Expense | 859 | 216 | 6 | 23 | 38 |
| Other Income | -22,015 | 6,100 | 69 | 25 | 0 |
| Pre-tax Income | -35,060 | -1,155 | -1,781 | -2,662 | -402 |
| Net Income Continuous | -35,060 | -1,155 | -1,781 | -2,662 | -402 |
| Net Income | $-35,060 | $-1,155 | $-1,781 | $-2,662 | $-402 |
| EPS Basic Total Ops | -2.26 | -0.10 | -0.14 | -0.26 | -0.05 |
| EPS Basic Continuous Ops | -2.26 | -0.10 | -0.14 | -0.26 | -0.05 |
| EPS Diluted Total Ops | -2.26 | -0.10 | -0.14 | -0.26 | -0.05 |
| EPS Diluted Continuous Ops | -2.26 | -0.10 | -0.14 | -0.26 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -2.26 | -0.08 | -0.14 | -0.26 | -0.05 |
| EBITDA(a) | $-12,166 | $-7,036 | $-1,833 | $-2,664 | $-364 |